Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: A randomized trial

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages 490-495

  Immer, Franz F ^a   Immer Bansi, Alexsandra S ^a   Trachsel, Nathalie ^a   Berdat, Pascal A ^a   Eigenmann, Verena ^a   Curatolo, Michele ^a   Carrel, Thierry P ^a  

^a PSI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; NAPROXEN; OPIATE; ROFECOXIB; TRAMADOL; TRAMAL RETARD; UREA;

ADULT; AGED; ANALGESIA; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DIGESTIVE SYSTEM ULCER; ENZYME INHIBITION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PAIN; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; THROMBOCYTE DYSFUNCTION; TREATMENT OUTCOME; UREA BLOOD LEVEL; VISUAL ANALOG SCALE;

AGED; ANALGESICS, OPIOID; CORONARY ARTERY BYPASS; CREATININE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; ETODOLAC; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PAIN, POSTOPERATIVE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRAMADOL; UREA;

EID: 0037316741     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04311-4     Document Type: Article

References (23)

1. Walther T, Falk V, Metz S, et al. Pain and quality of life after minimally invasive versus conventional cardiac surgery. Ann Thorac Surg 1999;67:1643-7.
2. Rapanos T, Murphy P, Szalai JP, Burlacoff L, Lam Mc Culloch J, Kay J. Rectal indomethacin reduces postoperative pain and morphine use after cardiac surgery. Can J Anesth 1999;46(8): 725-30.
3. Holmer Petterson P, Anjou Lindskog E, Öwall A. Patient-controlled versus nurse-controlled pain treatment after coronary artery bypass surgery. Acta Anaesthesiol Scand 2000;44:43-7.
4. Müller XM, Tinguely F, Tevaearai HT, Revelly JP, Chioléro R, von Segesser LK. Pain location, distribution, and intensity after cardiac surgery. Chest 2000;118:391-6.
5. Müller XM, Tinguely F, Tevaerai HAT, Revelly JP, Chiolero R, von Segesser LK. Pain pattern and left internal mammary artery grafting. Ann Thorac Surg 2000;70(6):2045-9.
6. Souter AJ, Fredmann B, White PF. Controversies in the perioperative use of nonsteroidal antiinflammatory drugs. Anesth Analg 1994;79:1178-90.
7. Ralley FE, Day FJ, Cheng DC. Pro: nonsteroidal antiinflammatory drugs should be routinely administered for postoperative analgesia after cardiac surgery. J Cardiothorac Vasc Anesth 2000;14(6):731-4.
8. Griffin M. Con: nonsteroidal anti-inflammatory drugs should not be routinely administered for postoperative analgesia after cardiac surgery. J Cardiothorac Vasc Anesth 2000;14(6):735-8.
9. Peterson WL, Cryer B. COX-1-Sparing NSAIDs - is the Enthusiasm Justified? JAMA 1999;282(20):1961-3.
10. Engel C, Lund B, Kristensen SS, Axel C, Nielsen JB. Indomethacin as an analgesic after hysterectomy. Acta Anaesth Scand 1989;33:498-501.
11. Reasbeck PG, Rice ML, Reasbeck JC. Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery. Lancet 1982;2:115-8.
12. Sims C, Johnson CM, Bergesio R, Delfos SJ, Avraamides EA. Rectal indomethacin for analgesia after appendectomy in children. Anaesth Intensive Care 1994;22:272-5.
13. Reuben S, Connelly NR, Lurie S, Klatt M, Gibson CS. Dose-response of ketorolac as an adjunct to patient-controlled analgesia morphine after spinal surgery. Anesth Analg 1994;79:1178-90.
14. Parker RK, Holtmann B, Smith I, White PF. Use of ketorolac after lower abdominal surgery. Effect on analgesic requirement and surgical outcome. Anesthesiology 1994;80:6-12.
15. Jackson LM, Hawkey CJ. COX-2 selective nonsteroidal antiinflammatory drugs: do they really offer any advantages? Drugs 2000;59(6):1207-16.
16. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-8.
17. Amadio P, Cummings DM, Amadio P. Nonsteroidal antiinflammatory drugs, tailoring therapy to achieve results and avoid toxicity. Postgrad Med 1993;93(4):73-6.
18. Bontoux D. Lombo-Radiculalgies: Efficacité, tolérance et bénéfice thérapeutique comparés de l'étodolac (600mg/j) du diclofénac (150mg/j) et du placebo. Rhumatologie 1990;42(7a):201-6.
19. Svendsen KB, Bech JN, Sorensen TB, Pedersen EB. A comparison of the effects of etodolac and ibuprofen on renal haemodynamics, tubular function, renin, vasopressin, and urinary excretion of albumin and α-glutathione and S-transferase in healthy subjects: a placebo-controlled cross-over study. Eur J Clin Pharmacol 2000;56:383.
20. Swan SK, Rudy DW, Lasseter KC, et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. Ann Intern Med 2000;133:1-9.
21. Harris RC Jr. Cyclooxygenase-2 inhibition and renal physiology. Am J Cardiol 2002;89(6A):10D-7D.
22. Schwartz JI, Vandormael K, Malice MP, et al. Clin Pharmacol Ther 2002;72(1):50-61.
23. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 1999;68(2): 493-8.